Committees

NeuroBo Pharmaceuticals' Shareholders Elect Hyung Heon Kim and Andrew I. Koven to NeuroBo's Board of Directors

Retrieved on: 
Monday, July 12, 2021

The NeuroBo Board now consists of seven directors, six of whom are considered independent directors.

Key Points: 
  • The NeuroBo Board now consists of seven directors, six of whom are considered independent directors.
  • "On behalf of the NeuroBo Board, I am delighted to welcome Hyung and Andrew to the Company.
  • I look forward to working with NeuroBo's Board and executive management to support the Company's future growth," commented Mr. Kim.
  • However, while NeuroBo may elect to update these forward-looking statements at some point in the future, NeuroBo specifically disclaims any obligation to do so.

Oportun Appoints Two New Independent Members to Board of Directors

Retrieved on: 
Monday, July 12, 2021

Effective as of September 1, 2021, the appointments expand Oportuns board from seven to nine members with the additions of Ginny Lee and Sandra Smith.

Key Points: 
  • Effective as of September 1, 2021, the appointments expand Oportuns board from seven to nine members with the additions of Ginny Lee and Sandra Smith.
  • After conducting an extensive search, our committee unanimously recommended Sandy and Ginny to the Oportun board.
  • Were confident that they will be outstanding independent directors, making the interests of our shareholders and stakeholders a priority, said Aida Alvarez, Chair, Oportun Nominating, Governance and Social Responsibility Committee.
  • With these additions, Oportuns corporate board now includes six of nine members who identify as either a woman or person of color.

BD Announces Two Future Directors for Diabetes Care Spinoff Company

Retrieved on: 
Monday, July 12, 2021

Additional appointments to the NewCo board of directors and executive team are expected to be announced prior to that date.

Key Points: 
  • Additional appointments to the NewCo board of directors and executive team are expected to be announced prior to that date.
  • He has extensive experience in spinoffs, having served as the inaugural chief executive at Exelis following its spinoff from ITT.
  • She will bring important perspectives on patient care services, global health and health policy to the NewCo board of directors.
  • There can be no assurance that BD's spinoff will in fact be completed in the manner described or at all.

Casey’s Announces Restaurant, Retail and Consumer Products Leader Greg Trojan Joins its Board of Directors

Retrieved on: 
Thursday, July 8, 2021

Mr. Trojan has over 25 years of experience leading national restaurant, retail and consumer products companies.

Key Points: 
  • Mr. Trojan has over 25 years of experience leading national restaurant, retail and consumer products companies.
  • View the full release here: https://www.businesswire.com/news/home/20210708005098/en/
    Greg Trojan appointed to Caseys Board of Directors (Photo: Business Wire)
    We are excited to welcome Greg to the Caseys Board of Directors as he provides significant restaurant, food service and other expertise to complement our current board capabilities.
  • Caseys and its shareholders will benefit immensely from his diverse, consumer-focused experience over nearly three decades, said Lynn Horak, Caseys Board Chair.
  • Adding Greg to the Caseys Board of Directors adds strategic expertise in areas that fuel the growth of our business focusing on the guest, leading an exceptional restaurant caliber foodservice program and being a retail leader.

Jack Henry's Chief Risk Officer Named Board Chair of The Institute of Internal Auditors

Retrieved on: 
Thursday, July 8, 2021

Today, the company announced that Charlie Wright, chief risk officer for Jack Henry, was named board chair of The Institute of Internal Auditors (IIA) Global Board of Directors.

Key Points: 
  • Today, the company announced that Charlie Wright, chief risk officer for Jack Henry, was named board chair of The Institute of Internal Auditors (IIA) Global Board of Directors.
  • The IIA is the internal audit profession's global voice, recognized authority, acknowledged leader, chief advocate, and principal educator.
  • As board chair, Wright will lead the 17-member Global Board, chair the Supervisory Committee, and preside over the General Assembly.
  • David Foss, board chair, president and chief executive officer for Jack Henry, added, "The addition of Charlie Wright as the board chair of IIA is a strategic and smart move.

Gerald O’Shaughnessy Issues Letter to GeoPark Shareholders

Retrieved on: 
Thursday, July 8, 2021

Gerald OShaughnessy, the co-founder, former Chairman and second largest shareholder of GeoPark Limited (GeoPark or the Company) (NYSE: GPRK) today issued the following letter to the Companys shareholders.

Key Points: 
  • Gerald OShaughnessy, the co-founder, former Chairman and second largest shareholder of GeoPark Limited (GeoPark or the Company) (NYSE: GPRK) today issued the following letter to the Companys shareholders.
  • These issues are core to GeoParks future, and the Board cannot leave shareholders in the dark on these matters.
  • GeoPark also has not sufficiently addressed its debt situation and continues to be one of the most leveraged companies among its peer group.
  • A vote AGAINST four incumbent directors is a vote to send a message that change is needed on the Board at GeoPark to benefit all of the Companys shareholders.

Essential Utilities Announces Appointment of David Ciesinski to Board of Directors

Retrieved on: 
Wednesday, July 7, 2021

Essential Utilities Inc. (NYSE: WTRG) announces the appointment of David Ciesinski to the Essential board of directors.

Key Points: 
  • Essential Utilities Inc. (NYSE: WTRG) announces the appointment of David Ciesinski to the Essential board of directors.
  • Ciesinski will serve as a member of the audit and the corporate governance committees of the board.
  • After a national search for a new director, the experience and expertise that Dave will bring to the Essential board is clear.
  • Ciesinski also earned a masters degree in marketing and finance from the Tepper School of Business at Carnegie Mellon University.

KBR Appoints Carlos A. Sabater and Lt. General Vincent R. Stewart to Board of Directors

Retrieved on: 
Wednesday, July 7, 2021

HOUSTON, July 7, 2021 /PRNewswire/ --KBR (NYSE: KBR) announced today the appointments of Carlos A. Sabater and Lt.General Vincent R. Stewart, USMC (Ret.)

Key Points: 
  • HOUSTON, July 7, 2021 /PRNewswire/ --KBR (NYSE: KBR) announced today the appointments of Carlos A. Sabater and Lt.General Vincent R. Stewart, USMC (Ret.)
  • Mr. Sabater is an accomplished global business executive, licensed certified public accountant, and qualified board of directors financial expert.
  • Mr. Sabater is currently a member of PDC Energy's Board of Directors, serving on the Audit and Compensation Committees.
  • Lt. General Stewart retired from the United States Marine Corps on April 5, 2019, after nearly four decades of service.

Scott+Scott Attorneys at Law LLP Investigates Social Capital Hedosophia Holding Corp. III’s Directors and Officers for Breach of Fiduciary Duties – IPOC, CLOV

Retrieved on: 
Wednesday, July 7, 2021

If you were an SCH III shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982 or [email protected] .

Key Points: 
  • If you were an SCH III shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982 or [email protected] .
  • Scott+Scott is investigating whether SCH IIIs board of directors or senior management failed to manage SCH III in an acceptable manner, in breach of their fiduciary duties to SCH III shareholders, and whether SCH IIIs shareholders suffered damages as a result.
  • On January 7, 2021, SCH III closed the merger transaction, with Clover Health continuing as the successor entity.
  • If you were an SCH III shareholder, you may have legal claims against SCH IIIs directors and officers.

The Glimpse Group Appoints Alexander Ruckdaeschel and Maydan Rothblum to its Board of Directors

Retrieved on: 
Wednesday, July 7, 2021

Alexander Ruckdaeschel has worked in the financial industry for over 20 years in the U.S. and Europe as a co-founder, partner and senior executive.

Key Points: 
  • Alexander Ruckdaeschel has worked in the financial industry for over 20 years in the U.S. and Europe as a co-founder, partner and senior executive.
  • He was also a partner with Alpha Plus Advisors and Nanostart AG, where he was the head of their U.S. group.
  • Mr. Ruckdaeschel has significant experience in startup operations as the manager of DAC Nanotech-Fund and Biotech-Fund, and sits on several boards.
  • Additionally, the Board of Directors approved the appointment of Maydan Rothblum to the Board.